Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Ratcliffe

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|September 5, 2015
Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewJames Sherwood, Simon Dearden, Marianne Ratcliffe, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2020
Cytology for PD-L1 testing: A systematic reviewJohn R Gosney, A-M Boothman, Marianne Ratcliffe, et al.
Oncotarget|December 17, 2016
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerNicola Normanno, Marc G Denis, Kenneth S Thress, et al.
Diagnostic Pathology|September 4, 2019
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinomaMagdalena Zajac, Marietta Scott, Marianne Ratcliffe, et al.
Molecular Immunology|December 22, 2009
Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defenceIan Doyle, Marianne Ratcliffe, Andrew Walding, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonistsChristopher A Luckhurst, Marianne Ratcliffe, Linda Stein, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC StudyAnne-Marie Boothman, Marietta Scott, Marianne Ratcliffe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS StudyMartin Reck, Koichi Hagiwara, Baohui Han, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE studyBaohui Han, Sergei Tjulandin, Koichi Hagiwara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic surveyYasushi Yatabe, Keith M Kerr, Ahmad Utomo, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Experimental & Clinical Cancer Research : CR|September 5, 2015
Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewJames Sherwood, Simon Dearden, Marianne Ratcliffe, et al.
Lung Cancer (Amsterdam, Netherlands)|February 3, 2020
Cytology for PD-L1 testing: A systematic reviewJohn R Gosney, A-M Boothman, Marianne Ratcliffe, et al.
Oncotarget|December 17, 2016
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerNicola Normanno, Marc G Denis, Kenneth S Thress, et al.
Diagnostic Pathology|September 4, 2019
Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinomaMagdalena Zajac, Marietta Scott, Marianne Ratcliffe, et al.
Molecular Immunology|December 22, 2009
Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defenceIan Doyle, Marianne Ratcliffe, Andrew Walding, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonistsChristopher A Luckhurst, Marianne Ratcliffe, Linda Stein, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2019
Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC StudyAnne-Marie Boothman, Marietta Scott, Marianne Ratcliffe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS StudyMartin Reck, Koichi Hagiwara, Baohui Han, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE studyBaohui Han, Sergei Tjulandin, Koichi Hagiwara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 8, 2014
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic surveyYasushi Yatabe, Keith M Kerr, Ahmad Utomo, et al.
Pageof 2